Callisto Pharmaceuticals CEO Dr. Gary S. Jacob Discusses Benefits Of Recent $5.14 Million Financing

LOS ANGELES--(BUSINESS WIRE)--Feb. 17, 2006--SmallCapInsights.com, the online source for exclusive commentary, research, interviews and other information about the Smallcap investment marketplace, today announced the availability of the first in a three-part series of exclusive online audio interviews with Dr. Gary S. Jacob, CEO and Chief Scientific Officer of Callisto Pharmaceuticals, Inc. (AMEX:KAL) (FWB:CA4), a developer of new drug treatments in the fight against cancer and other major health threats.

MORE ON THIS TOPIC